|
Session 9
Oral Abstracts
Prevention Strategies
Monday, 10 am-12 noon
Room: Ballroom B/C |
| 10:00 am 26 |
Comprehensive Pre-clinical Assessment of Microbicide Safety Using in vitro and Murine Models
Pedro Mesquita*, S Wilson, N Cheshenko, M Keller, B Galen, and B Herold
Albert Einstein Coll of Med, Bronx, NY, US |
| 10:15 am 27LB |
Protective Effect of Vaginal Lactobacillus on Genital HIV-1 RNA Concentrations: Longitudinal Data from a US Cohort Study
Jane Hitti*1, K Paul1, K Agnew1, R Gausman1, D Lockhart1, S Cohn2, A Luque2, and R Coombs1
1Univ of Washington, Seattle, US and 2Univ of Rochester, NY, US |
| 10:30 am 28LB |
Trial of Male Circumcision: Prevention of HSV-2 in Men and Vaginal Infections in Female Partners, Rakai, Uganda
Aaron Tobian*1, D Serwadda2, T Quinn1,3, G Kigozi4, S Reynolds1,3, F Makumbi4, T Suntoke1, S Watya5, M Wawer1, and R Gray1
1Johns Hopkins Univ, Baltimore, MD, US; 2Makerere Univ Sch of Publ Hlth, Kampala, Uganda; 3NIAID, NIH, Bethesda, MD, US; 4Rakai Hlth Sci Prgm, Entebbe, Uganda; and 5Makerere Univ, Kampala, Uganda |
| 10:45 am 29 |
3-Year Follow-up of Sexual Behavior and HIV Transmission Risk of Persons Taking ART in Rural Uganda
Rebecca Bunnell*1, J Ekwaru1, R King1, S Bechange1, D Moore2, K Khana1, W Were1, A Coutinho3, J Tappero1, and J Mermin1
1Global AIDS Prgm, CDC Uganda, Kampala; 2Univ of California, San Francisco, US; and 3AIDS Support Org, Kampala, Uganda |
| 11:00 am 30 |
Effect of a Novel Behavioral Intervention to Promote Condom Use among Female Sex Workers along Lagos, Nigeria –Cotonou, Benin International Border
Olusegun Busari*, O Busari, G Oligbu, and HIV STUDY GROUP
Federal Med Ctr, Ido-Ekiti, Nigeria |
| 11:15 am 31 |
Serosorting, but Not Seropositioning, Is Associated with Decreased Risk of HIV Seroconversion in the EXPLORE Study Cohort
Susan Philip*1, D Donnell2, X Yu2, E Vittinghoff3, and S Buchbinder1
1San Francisco Dept of Publ Hlth, CA, US; 2Statistical Ctr for HIV/AIDS Res and Prevention, Seattle, WA, US; and 3Univ of California, San Francisco, US |
| 11:30 am 32 |
HSV-2 Suppressive Therapy for Prevention of HIV Acquisition: Results of HPTN 039
Connie Celum*1, A Wald1, J Hughes1, J Sanchez2, S Reid3, S Delaney-Moretlwe4, F Cowan5, J Fuchs6, B Koblin7, L Corey8, and HPTN - 039
1Univ of Washington, Seattle, US; 2Impacta, Lima, Peru; 3Univ of Alabama at Birmingham, Ctr for Infectious Disease Res in Zambia, Lusaka; 4Univ of the Witwatersrand, Johannesburg, South Africa; 5Univ of California, San Francisco, US and Univ of Zimbabwe, Harare; 6San Francisco Dept of Publ Hlth, CA, US; 7New York Blood Ctr, New York, NY, US; and 8Fred Hutchinson Cancer Res Ctr, Seattle, WA, US |
| 11:45 am 33LB |
Trial of Male Circumcision in HIV+ Men, Rakai, Uganda: Effects in HIV+ Men and in Women Partners
Maria Wawer*1, G Kigozi2, D Serwadda3, F Makumbi3, F Nalugoda2, S Watya4, D Buwembo2, V Ssempijja2, L Moulton1, and R Gray1
1Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 2Rakai Hlth Sci Prgm, Kalisizo, Uganda; 3Makerere Univ Sch of Publ Hlth, Kampala, Uganda; and 4Makerere Univ Faculty of Med, Kampala, Uganda |
|
